The markets opened sharply higher with the Dow climbing 84 points to 15,678 as more jobs were added to the economy than expected. Nasdaq soared 43 points 3900.
On the upside
Salix Pharmaceuticals (Nasdaq: SLXP) will pay a premium of approximately $2.6 billion in cash to acquire Santarus (Nasdaq: SNTS).
Sequenom (Nasdaq: SQNM) narrowed third quarter losses as revenue surged.
Arena Pharmaceuticals (Nasdaq: ARNA) expanded its Belviq marketing agreement with Eisai.
On the downside
A Food and Drug Administration staff report noted safety concerns of Sanofi’s (Nasdaq: GCVRZ) multiple sclerosis treatment Lemtrada.
Nuverra Environmental Solutions (NYSE: NES) widened losses due to charges.
Tremor Video (NYSE: TRMR) widened third quarter losses prompting downgrades.
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 4 on the NYSE while advancers outpaced decliners by more than 2 to 1 on Nasdaq. The broader S&P 500 gained 11 points to 1758.
